{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(5)"],"submitter":["Jang EJ"],"pubmed_abstract":["<h4>Objectives</h4>We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.<h4>Methods</h4>We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.<h4>Results</h4>Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80"],"journal":["Osong public health and research perspectives"],"pagination":["377-381"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9633270"],"repository":["biostudies-literature"],"pubmed_title":["Presumed population immunity to SARS-CoV-2 in South Korea, April 2022."],"pmcid":["PMC9633270"],"pubmed_authors":["Lee S","Choe YJ","Kim YY","Jang EJ","Lim DS","Choe SA","Park YJ","Yi S","Kim J","Kim RK","Lee JH"],"additional_accession":[]},"is_claimable":false,"name":"Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.","description":"<h4>Objectives</h4>We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.<h4>Methods</h4>We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.<h4>Results</h4>Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-25T23:23:22.644Z","creation":"2025-04-06T09:23:24.196Z"},"accession":"S-EPMC9633270","cross_references":{"pubmed":["36328242"],"doi":["10.24171/j.phrp.2022.0209"]}}